# q03 rev 0 raw returns (tested_sha256 975f689e3df36539e485d7d4f7bdf18a71c63373825eeed9a2472e56f66b8316)

Fresh agents dispatched 2026-10-06 by the caller (Claude Code, Opus 5.5) with only the workspace
root, their own packet path and the verbatim question (closed-book: question only). Returns are
copied verbatim from the task notifications.

## Blind solver A (blind-solver, packet solver-1)

**answer:** 13,853 more observations (14,638 − 785)

**confidence:** high

**path:**
1. **Which studies.** D05 (docs/arxiv_2608_25172v1.txt), "Spatially orthogonal factor models for spatial transcriptomics…", is the brain spatial-factor study. Its abstract mentions "a human brain spatial transcriptomics case study". D02 (docs/arxiv_2606_16460v3.txt), "Module-structured mixture factor models for molecular subtype discovery…", is the autoimmune subtype study (RA and SLE). No other document mentions brain, autoimmune or a mixture factor model. D01's only hit is a passing mention of "latent factor models".
2. **What D05 means by "observations"** (D05 §1.1, line 29): "In this work, in both applied settings, we will use the term 'observations' for the rows of Y". It also says "in spatial transcriptomics rows typically correspond to genes", and that a spot together with its measurements is *not* called an observation: "we do not use this terminology here." So in the brain analysis, observations are genes.
3. **D05's main analysis** (§6, line 783): "We analyzed section 151675 … 3,592 in-tissue Visium spots and 33,538 gene features… The low-expression filtering retains 14,638 genes… We treat the filtered analysis as our main analysis". Appendix 10 (line 1055) agrees: "the main results shown in Figures 2 and 3 for the filtered analysis (14,638 genes)". So n = 14,638.
4. **D02's observations** (§2, line 47): "n and p are the number of samples and genes". §5.1 (line 431): "It contains a total of 785 samples, including 493 RA samples and 292 SLE samples". No sample exclusion is mentioned in §5.1 or Appendix A.
   - Table 1, the cluster assignments of the selected K=9, q=8 model, adds up to all 785. The RA row is 15+149+66+228+35 = 493 and the SLE row is 9+114+113+56 = 292.
   - The model's reported BIC also implies n = 785. From Table 4: 1,031,607 − 2(504,975.3) = 21,656.4, and 21,656.4 / ln 785 (6.6657) ≈ 3,249.
   - That matches the parameter count: 3×979 + 9×19 + 19×(8−1) + 8 = 3,249.
   - The WGCNA model checks out the same way: 19,697.2 / 6.6657 ≈ 2,955 = 3×975 + 12 + 15 + 3.
5. **Calculation:** 14,638 − 785 = 13,853.

**minimal_documents:** D05 and D02, both required. No other packet document contains either figure.

**readings:**
- **Spots as observations:** This uses the general field meaning that D05 explicitly rejects. All 3,592 spots gives 3,592 − 785 = 2,807. Excluding the 400 held-out spots gives 3,192 − 785 = 2,407.
- **Wrong analysis chosen:** The full-gene appendix analysis gives 33,538 − 785 = 32,753. The 3,000-gene variable-gene analysis gives 3,000 − 785 = 2,215. Neither is the stated main analysis.
- **Other D02 models or counts:** The WGCNA-based comparison model uses the same 785 samples, so the answer is unchanged. D02's gene counts (9,671 raw, 979 retained) count variables, not observations, in that paper's model.

**gaps:**
- The packet has no original PDFs and no Dnn.layout.txt files. docs\ holds only .txt sources and the manifest lists method "text" with pages null, so I couldn't inspect any page images.
- The decisive figures are in body text and repeat consistently (14,638 appears twice; 785 is confirmed by Table 1 and by the BIC), so this doesn't affect the result.
- I read D02 and D05 in their relevant sections and appendices. I read only the first 40 lines of D01, D03, D04 and D06, plus searched them for brain, autoimmune and mixture factor terms.

**contaminated:** no

## Closed-book solver (closed-book-solver, question only)

answer: unknown

confidence: low

basis: I don't have the two source documents, and I can't tell which papers "the brain spatial-factor study" and "the autoimmune subtype study" are. One might be a spatial transcriptomics factor model such as NSF or MEFISTO, applied to mouse brain Visium or Slide-seq data. The other might be a mixture of factor analyzers model used to find autoimmune subtypes. Even so, I can't reliably recall the observation counts (spots, beads or patients) for either model. Without both numbers I can't work out the difference, and any figure I gave would be made up.

contaminated: no

## Shortcut auditor (shortcut-auditor, packet shortcut)

answer: 13,853 more observations (14,638 − 785).

verdict: clear

shortest_path:
1. The brain study is D05 (`docs/arxiv_2608_25172v1.txt`), the spatially orthogonal factor model (SOFM) applied to DLPFC brain tissue. In Section 1.1 the paper defines its terms: "we will use the term 'observations' for the rows of Y". It also says that in spatial transcriptomics "rows typically correspond to genes". It rejects the other usage, where an observation is a spatial location: "we do not use this terminology here."
2. D05 Section 6 gives the main tissue analysis size. Section 151675 has "3,592 in-tissue Visium spots and 33,538 gene features". Then: "The low-expression filtering retains 14,638 genes … We treat the filtered analysis as our main analysis". Appendix 10 repeats "main results … for the filtered analysis (14,638 genes)". So the main model has 14,638 observations.
3. The autoimmune study is D02 (`docs/arxiv_2606_16460v3.txt`), the module-structured mixture factor model. Section 5.1 says the dataset "contains a total of 785 samples, including 493 RA samples and 292 SLE samples". Section 5.2 says the model "is fitted to the combined dataset". D02 also counts by sample when it refers to observations: "the posterior probability that observation i belongs to cluster k".
4. Two checks confirm the 785:
   - Table 1's clusters add up to 785: RA 15+149+66+228+35 = 493 and SLE 9+114+113+56 = 292.
   - The BIC values in Table 4 imply n = 785. For the MAD model, 1,031,607 − 2(504,975.3) = 21,656.4, and 21,656.4 / ln 785 (6.6657) ≈ 3,249 parameters. That matches the parameter count exactly: 8 + 979 + 171 + 133 + 979 + 979. The WGCNA model gives a similar exact match of 2,955 parameters.
5. Calculation: 14,638 − 785 = 13,853.

sufficient_documents: D05 and D02, which are both necessary. Neither document gives both numbers or refers to the other study, and no other packet document can stand in for either.

searches:
- **Terms searched:** "brain", "autoimmune", "lupus", "rheumatoid", "DLPFC", "spatial transcriptomic", "mixture factor". These matched only D02 and D05.
- **Answer-shaped values:** I searched for "13,853"/"13853" in both text/ and docs/ and found nothing. I also searched for the inputs 14,638, 785, 3,592, 33,538, 3,192 and 2,807.
- **Wording checks in the original docs:** "main analysis", "term 'observations'", "retains 14,638", "observation i belongs" and "fitted to the combined dataset". The docs/ wording matches the extracted text.
- **Coverage:** I read D01–D05 in full and D06 through line 1097. D01 (leukemia DPMM, 72 samples) is a possible distractor but is neither autoimmune nor a factor model. D03 (order statistics) and D04 (battery ageing) are unrelated. D06 is null-space SVD theory, and a keyword count found no brain or autoimmune terms in it.

readings/gaps:
- **Alternative readings, all rejected:**
  - Counting brain "observations" as spots gives 3,592 − 785 = 2,807, or 3,192 − 785 = 2,407 if the 400 held-out spots are removed. D05 explicitly rejects spots as observations.
  - Using the full-gene analysis gives 33,538 − 785 = 32,753. Using the HVG analysis gives 3,000 − 785 = 2,215. The paper names the filtered analysis as the main one.
  - Counting D02's observations as genes gives 14,638 − 979 = 13,659. D02 indexes observations by sample, and the BIC check fixes n = 785.
  - Using RA-only (493) or SLE-only (292) counts is ruled out because the model was fitted to the combined dataset.
- **Difficulty risk (not a shortcut):** both inputs are easy to find by keyword, and the answer is a plain difference. The main trap is spots versus genes, and D05 settles it explicitly.
- **Gaps:** D06 lines 1098–1362 were not read in full, though the keyword count covers them. Figures in all documents are available only as extracted text.

## Blind solver B (blind-solver, packet solver-2)

answer: 13,853 more observations. The brain model's main analysis had 14,638 and the autoimmune model had 785.

confidence: high

path:
1. **Identifying the studies.**
   - D05 (docs/arxiv_2608_25172v1.txt) is the brain spatial-factor study: "Spatially orthogonal factor models for spatial transcriptomics and remote sensing data". It includes a "human brain spatial transcriptomics case study" from the DLPFC.
   - D02 (docs/arxiv_2606_16460v3.txt) is the autoimmune subtype study: "Module-structured mixture factor models for molecular subtype discovery in transcriptomic data". It covers SLE and RA.
   - D01 is a leukemia mixture model with 72 samples, so it is not the autoimmune study. D03, D04 and D06 cover unrelated topics.
2. **What D05 calls an observation** (D05.txt line 29). "Suppose Y is an n×m matrix, where the rows index observations or features… in spatial transcriptomics rows typically correspond to genes… In this work, in both applied settings, we will use the term 'observations' for the rows of Y and spatial locations for the columns." It adds that the field sometimes uses "observation" to mean a spatial location, but "we do not use this terminology here." So in the brain model, observations are genes.
3. **D05's main analysis** (D05.txt line 783). The section analysed "contains expression measurements for 3,592 in-tissue Visium spots and 33,538 gene features". The filtering step "retains 14,638 genes", and "We treat the filtered analysis as our main analysis".
   - The appendix confirms this (line 1055): "the main results shown in Figures 2 and 3 for the filtered analysis (14,638 genes)".
   - The model was fitted "using k = 7 factors and 400 held-out spots" (line 815). The held-out spots reduce the number of locations, not the number of observations.
4. **D02's observation count.**
   - Line 47 defines n as the number of samples: "n and p are the number of samples and genes".
   - Line 431: "It contains a total of 785 samples, including 493 RA samples and 292 SLE samples".
   - Line 443: the model "is fitted to the combined dataset".
   - Table 1 (lines 460–461) agrees. The RA row is 15+149+66+228+35 = 493 and the SLE row is 9+114+113+56 = 292, for 785 in total.
   - Table 5 (the WGCNA-based comparison model) also adds up to 493 + 292 = 785.
   - D02 has no simulation study, so there is no other sample size to compete with 785.
5. **Calculation:** 14,638 − 785 = 13,853.
6. **Source check:** a search of the original docs/*.txt files found the same wording and figures ("14,638 genes", "main analysis", "use the term 'observations'", "total of 785 samples").

minimal_documents: D05 and D02. Both are needed, and no other document in the packet can replace either one.

readings:
- **Spots as observations.** This follows the field's common usage, which D05 explicitly rejects. All 3,592 spots give 3,592 − 785 = 2,807. Leaving out the 400 held-out spots gives 3,192 − 785 = 2,407.
- **Full-gene analysis instead of the main one.** 33,538 − 785 = 32,753. This analysis is in the appendix and is not the main one.
- **3,000-gene (most variable genes) analysis.** 3,000 − 785 = 2,215. This is not the main analysis either.

gaps:
- Both sources are plain text (the manifest says "method": "text" with no pages), so there were no PDF pages or layout files to inspect.
- D01, D03, D04 and D06 were read only at the opening (about 40 lines each) and covered by keyword searches. They were not read in full.

contaminated: no
